1. Home
  2. GENC vs ADAG Comparison

GENC vs ADAG Comparison

Compare GENC & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gencor Industries Inc.

GENC

Gencor Industries Inc.

N/A

Current Price

$17.50

Market Cap

254.2M

Sector

Industrials

ML Signal

N/A

Logo Adagene Inc.

ADAG

Adagene Inc.

N/A

Current Price

$1.75

Market Cap

222.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GENC
ADAG
Founded
N/A
2011
Country
United States
China
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
254.2M
222.2M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
GENC
ADAG
Price
$17.50
$1.75
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
★ $21.00
$9.91
AVG Volume (30 Days)
32.5K
★ 196.5K
Earning Date
12-08-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 8.08
N/A
EPS
★ 0.89
N/A
Revenue
★ $48,943,000.00
N/A
Revenue This Year
$1.78
N/A
Revenue Next Year
$25.68
$129.59
P/E Ratio
$19.90
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$12.22
$1.50
52 Week High
$20.19
$4.85

Technical Indicators

Market Signals
Indicator
GENC
ADAG
Relative Strength Index (RSI) 52.07 31.30
Support Level $16.75 N/A
Resistance Level $18.11 $3.50
Average True Range (ATR) 0.55 0.26
MACD 0.05 -0.03
Stochastic Oscillator 70.15 0.94

Price Performance

Historical Comparison
GENC
ADAG

About GENC Gencor Industries Inc.

Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

Share on Social Networks: